Publicacions en què col·labora amb Marta Gomez Sanchez (20)

2022

  1. Long-Term Effectiveness of a Smartphone App and a Smart Band on Arterial Stiffness and Central Hemodynamic Parameters in a Population with Overweight and Obesity (Evident 3 Study): Randomised Controlled Trial

    Nutrients, Vol. 14, Núm. 22

  2. Retinal blood vessel calibre and vascular ageing in a general Spanish population: A EVA study

    European Journal of Clinical Investigation, Vol. 52, Núm. 2

  3. Vascular target organ damage in patients with Philadelphia negative myeloproliferative syndrome: A propensity score analysis

    Medicina Clinica, Vol. 158, Núm. 11, pp. 503-508

2021

  1. Reference values of central blood pressure and central haemodynamic parameters and their relationship with cardiovascular risk factors in a Spanish population: early vascular ageing study

    Journal of hypertension, Vol. 39, Núm. 11, pp. 2147-2156

  2. Relationship of healthy vascular aging with lifestyle and metabolic syndrome in the general Spanish population. The EVA study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 854-861

2020

  1. Reference values of arterial stiffness parameters and their association with cardiovascular risk factors in the Spanish population. The EVA Study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 43-52

  2. Vascular aging and its relationship with lifestyles and other risk factors in the general Spanish population: Early Vascular Ageing Study

    Journal of hypertension, Vol. 38, Núm. 6, pp. 1110-1122

2019

  1. Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study)

    PLoS ONE, Vol. 14, Núm. 1

  2. Reclassification by applying the Framingham equation 30 years to subjects with intermediate cardiovascular risk. MARK study

    Medicina Clinica, Vol. 153, Núm. 9, pp. 351-356

2018

  1. A body shape index and vascular structure and function in Spanish adults (MARK study) A cross-sectional study

    Medicine (United States), Vol. 97, Núm. 47

2016

  1. Evolution of target organ damage and haemodynamic parameters over 4years in patients with increased insulin resistance: The LOD-DIABETES prospective observational study

    BMJ Open, Vol. 6, Núm. 6

  2. Vascular structure and function and their relationship with health-related quality of life in the MARK study

    BMC Cardiovascular Disorders, Vol. 16, Núm. 1

2015

  1. Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: A case series report

    Cardiovascular Diabetology, Vol. 14, Núm. 1

  2. Gender differences in the progression of target organ damage in patients with increased insulin resistance: The LOD-DIABETES study

    Cardiovascular Diabetology, Vol. 14, Núm. 1

2014

  1. Relationship between electrocardiographic left ventricular hypertrophy criteria and vascular structure and function parameters in hypertensive patients

    Journal of Human Hypertension, Vol. 28, Núm. 3, pp. 186-192

2013

  1. Relationship between uric acid and vascular structure and function in hypertensive patients and sex-related differences

    American Journal of Hypertension, Vol. 26, Núm. 5, pp. 599-607

2012

  1. Ambulatory arterial stiffness indices and target organ damage in hypertension

    BMC Cardiovascular Disorders, Vol. 12

  2. Protocol for measuring carotid intima-media thickness that best correlates with cardiovascular risk and target organ damage

    American Journal of Hypertension, Vol. 25, Núm. 9, pp. 955-961

  3. Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex

    BMC Cardiovascular Disorders, Vol. 12

2011

  1. Yearly evolution of organ damage markers in diabetes or metabolic syndrome: Data from the LOD-DIABETES study

    Cardiovascular Diabetology, Vol. 10